Gide Warsaw has advised Polish Enterprise Fund VII on the sale of Nu-Med to Affidea. Wiercinski Kwiecinski Baehr advised Affidea.
The transaction remains contingent on regulatory approval.
Polish Enterprise Fund VII is a private equity fund managed by Enterprise Investors.
Nu-Med is a Polish company specializing in radiotherapy treatment for cancer patients.
Affidea is a pan-European provider of specialist healthcare services, including cancer care, advanced diagnostic imaging, and community-based polyclinics.
In 2023, Gide advised on Advanced Protection Systems Investment by Enterprise Investors (as reported by CEE Legal Matters on August 30, 2023).
The Gide team included Partner Pawel Grzeskowiak, Counsel Wojciech Czyzewski, and Associate Magdalena Zawislak.
The WKB team included Partners Jakub Jedrzejak, Anna Kratiuk, and Wojciech Kulczyk, Managing Associate Magdalena Purol, Senior Associate Anna Wiktorow-Bojska, Associates Zuzanna Cybulska and Filip Rybak, and Junior Associate Jolanta Prystupa.
